50 research outputs found
CITED2 and the modulation of the hypoxic response in cancer
CITED2 (CBP/p300-interacting transactivator with Glu/Asp-rich C-terminal domain, 2) is a ubiquitously expressed protein exhibiting a high affinity for the CH1 domain of the transcriptional co-activators CBP/p300, for which it competes with hypoxia-inducible factors (HIFs). CITED2 is particularly efficient in the inhibition of HIF-1α-dependent transcription in different contexts, ranging from organ development and metabolic homeostasis to tissue regeneration and immunity, being also potentially involved in various other physiological processes. In addition, CITED2 plays an important role in inhibiting HIF in some diseases, including kidney and heart diseases and type 2-diabetes. In the particular case of cancer, CITED2 either functions by promoting or suppressing cancer development depending on the context and type of tumors. For instance, CITED2 overexpression promotes breast and prostate cancers, as well as acute myeloid leukemia, while its expression is downregulated to sustain colorectal cancer and hepatocellular carcinoma. In addition, the role of CITED2 in the maintenance of cancer stem cells reveals its potential as a target in non-small cell lung carcinoma and acute myeloid leukemia, for example. But besides the wide body of evidence linking both CITED2 and HIF signaling to carcinogenesis, little data is available regarding CITED2 role as a negative regulator of HIF-1α specifically in cancer. Therefore, comprehensive studies exploring further the interactions of these two important mediators in cancer-specific models are sorely needed and this can potentially lead to the development of novel targeted therapies.info:eu-repo/semantics/publishedVersio
Tribbles gene expression profiles in colorectal cancer
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of death due to cancer in the world. Therefore, the identification of novel druggable targets is urgently needed. Tribbles proteins belong to a pseudokinase family, previously recognized in CRC as oncogenes and potential therapeutic targets. Here, we analyzed the expression of TRIB1, TRIB2, and TRIB3 simultaneously in 33 data sets from CRC based on available GEO profiles. We show that all three Tribbles genes are overrepresented in CRC cell lines and primary tumors, though depending on specific features of the CRC samples. Higher expression of TRIB2 in the tumor microenvironment and TRIB3 overexpression in an early stage of CRC development, unveil a potential and unexplored role for these proteins in the context of CRC. Differential Tribbles expression was also explored in diverse cellular experimental conditions where either genetic or pharmacological approaches were used, providing novel hints for future research. This comprehensive bioinformatic analysis provides new insights into Tribbles gene expression and transcript regulation in CRC.info:eu-repo/semantics/publishedVersio
Human stem cells for cardiac disease modeling and preclinical and clinical applications—are we on the road to success?
Cardiovascular diseases (CVDs) are pointed out by the World Health Organization (WHO) as the leading cause of death, contributing to a significant and growing global health and economic burden. Despite advancements in clinical approaches, there is a critical need for innovative cardiovascular treatments to improve patient outcomes. Therapies based on adult stem cells (ASCs) and embryonic stem cells (ESCs) have emerged as promising strategies to regenerate damaged cardiac tissue and restore cardiac function. Moreover, the generation of human induced pluripotent stem cells (iPSCs) from somatic cells has opened new avenues for disease modeling, drug discovery, and regenerative medicine applications, with fewer ethical concerns than those associated with ESCs. Herein, we provide a state-of-the-art review on the application of human pluripotent stem cells in CVD research and clinics. We describe the types and sources of stem cells that have been tested in preclinical and clinical trials for the treatment of CVDs as well as the applications of pluripotent stem-cell-derived in vitro systems to mimic disease phenotypes. How human stem-cell-based in vitro systems can overcome the limitations of current toxicological studies is also discussed. Finally, the current state of clinical trials involving stem-cell-based approaches to treat CVDs are presented, and the strengths and weaknesses are critically discussed to assess whether researchers and clinicians are getting closer to success.B.M.S. was awarded with a Ph.D. fellowship (reference: 2022.13253.BDANA)
by Fundação para a Ciência e Tecnologia (FCT). S.M.C is supported by a Stimulus of Scientific
Employment, Individual Support (2020.01532.CEECIND) by FCT. J.B. is grateful to the FCT and the
Comissão de Coordenação e Desenvolvimento Regional do Algarve (CCDR Algarve) for the project
ALG-45-2020-41 and to Algarve Biomedical Center (ABC) for the award “Bolsa de Investigação
Translacional—José Mariano Gago by ABC, 2022”. M.T.F. thanks the FCT for funding the project with
the reference 2022.09209.PTDC.info:eu-repo/semantics/publishedVersio
Peritoneal protein loss, inflammation, and nutrition: refuting myths
Peritoneal protein loss (PPL) has been correlated with mortality, malnutrition and
inflammation. More recently overhydration was brought to the equation. This study
aims to review classic and recent factors associated with PPL. Prevalent and incident
peritoneal dialysis (PD) patients were included. Dialysate and serum IL-6 was obtained
during PET. Hydration and nutritional status were assessed by bio-impedance. Linear
regression and Cox regression were performed. The 78 included patients presented
median values of PPL 4.8 g/24 h, serum IL-6: 5.1 pg/mL, and IL-6 appearance rate
153.5 pg/min. Mean extracellular water excess (EWexc) was 0.88 ± 0.94 L, and lean
body mass index (LBMI) 17.3 ± 2.4 kg/m2
. After mean follow-up of 33.9 ± 29.3 months,
12 patients died. Linear univariable analysis showed positive associations between
PPL and small solute transport, body composition (LBMI and EWexc), comorbidities
and performing CAPD (vs. cycler). PPL correlated positively with dialysate appearance
rate of IL-6, but not with serum IL-6. Linear multivariable analysis confirmed positive
association between PPL and EWexc (p = 0.012; 95%CI: 4.162–31.854), LBMI (p =
0.008; 95%CI: 1.720–11.219) and performing CAPD (p = 0.023; 95%CI: 4.375–54.190).
In survival analysis, no relationship was found between mortality and PPL. Multivariable
Cox regression showed Charlson Comorbidity Index (HR: 1.896, 95%CI: 1.235–2.913),
overhydration (HR: 10.034, 95%CI: 1.426–70.587) and lower PPL (HR: 0.576, 95%CI:
0.339–0.978) were predictors for mortality. Overhydration, was a strong predictor of
PPL, overpowering variables previously reported as determinants of PPL, namely clinical
correlates of endothelial dysfunction or local inflammation. PPL were not associated with
malnutrition or higher mortality, emphasizing the importance of volume overload control
in PD patients.info:eu-repo/semantics/publishedVersio
Cdkn2a inactivation promotes malignant transformation of mouse immature thymocytes before the β-selection checkpoint
CDKN2A deletion is the most frequent genetic alteration in T-cell
acute lymphoblastic leukemia (T-ALL), occurring across all molecular and immunophenotypic subtypes. CDKN2A encodes two functionally unrelated tumor suppressor proteins, ARF and INK4a,
which are critical regulators of cell cycle and proliferation. Arf has
been reported to suppress T-ALL development in post−b-selection
thymocytes, but whether CDKN2A acts as a tumor suppressor gene
in immature, pre−b-selection thymocytes remains to be elucidated.
Resorting to a Rag2-deficient model of T-ALL, driven by the ETV6::
JAK2 fusion, we report that Cdkn2a haploinsufficiency at early
stages of T-cell development facilitates leukemia developmentPPBI-POCI-01-0145-FEDER-022122; POCI-01-0145-FEDER-007274; NORTE01-0145-FEDER-000029info:eu-repo/semantics/publishedVersio
THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
Breast cancer (BC) is the most frequently diagnosed cancer and a leading cause of death among
women worldwide. Early BC is potentially curable, but the mortality rates still observed among BC patients demon‑
strate the urgent need of novel and more efective diagnostic and therapeutic options. Limitless self-renewal is a
hallmark of cancer, governed by telomere maintenance. In around 95% of BC cases, this process is achieved by telom‑
erase reactivation through upregulation of the human telomerase reverse transcriptase (hTERT). The hypermethylation
of a specifc region within the hTERT promoter, termed TERT hypermethylated oncological region (THOR) has been
associated with increased hTERT expression in cancer. However, its biological role and clinical potential in BC have
never been studied to the best of our knowledge. Therefore, we aimed to investigate the role of THOR as a biomarker
and explore the functional impact of THOR methylation status in hTERT upregulation in BC.info:eu-repo/semantics/publishedVersio
Rett syndrome with and without detected MECP2 mutations: an attempt to redefine phenotypes
Background: The diagnosis of Rett syndrome (RTT) is based on a set of clinical criteria, irrespective of mutation status. The aims of this study were (1) to define the clinical differences existing between patients with Rett syndrome with (Group I) and without a MECP2 mutation (Group II), and (2) to characterize the phenotypes associated with the more common MECP2 mutations. Patients and methods: We analyzed 87 patients fulfilling the clinical criteria for RTT. All were observed and videotaped by the same paediatric neurologist. Seven common mutations were considered separately, and associated clinical features analysed. Results: Comparing Group I and II, we found differences concerning psychomotor development prior to onset, acquisition of propositive manipulation and language, and evolving autistic traits. Based on age at observation, we found differences in eye pointing, microcephaly, growth, number of stereotypies, rigidity, ataxia and ataxic-rigid gait, and severity score. Patients with truncating differed from those with missense mutations regarding acquisition of propositive words and independent gait, before the beginning of the disease, and microcephaly, growth, foot length, dystonia, rigidity and severity score, at the time of observation. Patients with the R168X mutation had a more severe phenotype, whereas those with R133C showed a less severe one. Patients with R294X had a hyperactive behaviour, and those with T158M seemed to be particularly ataxic and rigid. Conclusion: A clear regressive period (with loss of prehension and language, deceleration of growth) and the presence of more than three different stereotypies, rigidity and ataxic-rigid gait seemed to be very helpful in differentiating Group I from Group II
Acute and Long-Term Effects of Hyperthermia in B16-F10 Melanoma Cells
OBJECTIVE: Hyperthermia uses exogenous heat induction as a cancer therapy. This work addresses the acute and long-term effects of hyperthermia in the highly metastatic melanoma cell line B16-F10. MATERIALS AND METHODS: Melanoma cells were submitted to one heat treatment, 45°C for 30 min, and thereafter were kept at 37°C for an additional period of 14 days. Cultures maintained at 37°C were used as control. Cultures were assessed for the heat shock reaction. RESULTS: Immediately after the heat shock, cells began a process of fast degradation, and, in the first 24 h, cultures showed decreased viability, alterations in cell morphology and F-actin cytoskeleton organization, significant reduction in the number of adherent cells, most of them in a process of late apoptosis, and an altered gene expression profile. A follow-up of two weeks after heat exposure showed that viability and number of adherent cells remained very low, with a high percentage of early apoptotic cells. Still, heat-treated cultures maintained a low but relatively constant population of cells in S and G(2)/M phases for a long period after heat exposure, evidencing the presence of metabolically active cells. CONCLUSION: The melanoma cell line B16-F10 is susceptible to one hyperthermia treatment at 45°C, with significant induced acute and long-term effects. However, a low but apparently stable percentage of metabolically active cells survived long after heat exposure
Understanding Conformational Dynamics of Complex Lipid Mixtures Relevant to Biology
This is a perspective article entitled “Frontiers in computational biophysics: understanding conformational dynamics of complex lipid mixtures relevant to biology” which is following a CECAM meeting with the same name.Fil: Friedman, Ran. Linnæus University; ArgentinaFil: Khalid, Syma. University of Southampton; Reino UnidoFil: Aponte Santamaría, Camilo. Ruprecht-Karls-Universität Heidelberg; Alemania. Universidad de los Andes; ColombiaFil: Arutyunova, Elena. University of Alberta; CanadáFil: Becker, Marlon. Westfälische Wilhelms Universität; AlemaniaFil: Boyd, Kevin J.. University of Connecticut; Estados UnidosFil: Christensen, Mikkel. University Aarhus; DinamarcaFil: Coimbra, João T. S.. Universidad de Porto; PortugalFil: Concilio, Simona. Universita di Salerno; ItaliaFil: Daday, Csaba. Heidelberg Institute for Theoretical Studies; AlemaniaFil: Eerden, Floris J. van. University of Groningen; Países BajosFil: Fernandes, Pedro A.. Universidad de Porto; PortugalFil: Gräter, Frauke. Heidelberg University; Alemania. Heidelberg Institute for Theoretical Studies; AlemaniaFil: Hakobyan, Davit. Westfälische Wilhelms Universität; AlemaniaFil: Heuer, Andreas. Westfälische Wilhelms Universität; AlemaniaFil: Karathanou, Konstantina. Freie Universität Berlin; AlemaniaFil: Keller, Fabian. Westfälische Wilhelms Universität; AlemaniaFil: Lemieux, M. Joanne. University of Alberta; CanadáFil: Marrink, Siewert J.. University of Groningen; Países BajosFil: May, Eric R.. University of Connecticut; Estados UnidosFil: Mazumdar, Antara. University of Groningen; Países BajosFil: Naftalin, Richard. Colegio Universitario de Londres; Reino UnidoFil: Pickholz, Mónica Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Física de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Física de Buenos Aires; ArgentinaFil: Piotto, Stefano. Universita di Salerno; ItaliaFil: Pohl, Peter. Johannes Kepler University; AustriaFil: Quinn, Peter. Colegio Universitario de Londres; Reino UnidoFil: Ramos, Maria J.. Universidad de Porto; PortugalFil: Schiøtt, Birgit. University Aarhus; DinamarcaFil: Sengupta, Durba. National Chemical Laboratory India; IndiaFil: Sessa, Lucia. Universita di Salerno; ItaliaFil: Vanni, Stefano. University Of Fribourg;Fil: Zeppelin, Talia. University Aarhus; DinamarcaFil: Zoni, Valeria. University of Fribourg; SuizaFil: Bondar, Ana-Nicoleta. Freie Universität Berlin; AlemaniaFil: Domene, Carmen. University of Oxford; Reino Unido. University of Bath; Reino Unid
The era of reference genomes in conservation genomics
Progress in genome sequencing
now enables the large-scale
generation of reference genomes.
Various international initiatives
aim to generate reference genomes
representing global biodiversity.
These genomes provide
unique insights into genomic diversity
and architecture, thereby enabling
comprehensive analyses
of population and functional
genomics, and are expected
to revolutionize conservation
genomics